Humira Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Prognosis in UC After First Biological
Condition:   Ulcerative Colitis Intervention:   Biological: infliximab, adalimumab, golimumab, vedolizumab, ustekinumab Sponsor:   Tampere University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2022 Category: Research Source Type: clinical trials

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Condition:   Plaque Psoriasis Interventions:   Drug: Humira (Adalimumab);   Drug: SB5 (Adalimumab Biosimilar) Sponsor:   Samsung Bioepis Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2022 Category: Research Source Type: clinical trials